Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

45.28

+0.49 (1.09%)

Feb 6, 2026, 4:00 PM EST - Market closed

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,642	4,742	2,377	985	1,340	465
Market Cap Growth	27.68%	99.50%	141.36%	-26.50%	188.40%	-23.56%
Enterprise Value	3,599	3,932	1,874	620	1,151	283
Last Close Price	45.28	51.13	35.58	18.30	28.41	14.11
PS Ratio	3023.93	4563.69	592.26	207.88	1242.80	6542.73
PB Ratio	3.99	3.58	4.41	3.11	4.04	2.75
P/TBV Ratio	4.33	3.58	4.41	3.11	4.04	2.75
EV/Sales Ratio	2344.36	3783.97	467.04	130.82	1067.39	3982.45
Debt / Equity Ratio	0.05	0.04	0.10	0.01	0.01	0.03
Asset Turnover	0.00	0.00	0.01	0.01	0.00	0
Quick Ratio	14.73	22.83	12.92	12.17	20.96	16.47
Current Ratio	15.12	23.05	13.07	12.45	21.55	16.92
Return on Equity (ROE)	-44.42%	-32.02%	-50.16%	-50.57%	-42.98%	-51.61%
Return on Assets (ROA)	-28.00%	-20.46%	-28.18%	-29.84%	-25.19%	-29.85%
Return on Capital Employed (ROCE)	-42.60%	-24.60%	-37.60%	-51.70%	-32.10%	-43.30%
Earnings Yield	-9.12%	-6.29%	-9.03%	-16.65%	-8.04%	-15.89%
FCF Yield	-7.63%	-4.85%	-7.20%	-11.87%	-6.64%	-13.39%
Buyback Yield / Dilution	-24.75%	-39.11%	-11.71%	-35.24%	-26.24%	-25.95%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q